These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9009099)
1. Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies. Lorgeot V; Praloran V; Turlure P; Denizot Y Leukemia; 1997 Feb; 11(2):311-2. PubMed ID: 9009099 [No Abstract] [Full Text] [Related]
2. Leukemia inhibitory factor concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies. Lorgeot V; Trimoreau F; Gachard N; Praloran V; Denizot Y Eur Cytokine Netw; 1997 Mar; 8(1):57-9. PubMed ID: 9110149 [TBL] [Abstract][Full Text] [Related]
3. Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay. Ren SG; Seliktar J; Li X; Braunstein GD; Melmed S J Clin Endocrinol Metab; 1998 Apr; 83(4):1275-83. PubMed ID: 9543156 [TBL] [Abstract][Full Text] [Related]
4. Lack of detection of leukaemia inhibitory factor in the sera of psoriatic patients. Szepietowski JC; Bielicka E; Noworolska A Dermatology; 2000; 200(1):88-9. PubMed ID: 10681631 [No Abstract] [Full Text] [Related]
5. ELISA detection of circulating levels of LIF, OSM, and CNTF in septic shock. Guillet C; Fourcin M; Chevalier S; Pouplard A; Gascan H Ann N Y Acad Sci; 1995 Jul; 762():407-9. PubMed ID: 7668543 [No Abstract] [Full Text] [Related]
7. One-year enzyme-linked immunosorbent assay follow-up of human interleukin for Da cells/leukemia inhibitory factor in blood and urine of 22 kidney transplant recipients. Morel D; Taupin JL; Combe C; Potaux L; Gualde N; Moreau JF Transplantation; 1994 Dec; 58(11):1190-5. PubMed ID: 7992361 [TBL] [Abstract][Full Text] [Related]
8. Serum IL-10 and IL-13 concentrations in patients with haematological malignancies. Denizot Y; Turlure P; Bordessoule D; Trimoreau F; Praloran V Cytokine; 1999 Aug; 11(8):634-5. PubMed ID: 10433812 [No Abstract] [Full Text] [Related]
9. Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis. Villers D; Dao T; Nguyen JM; Bironneau E; Godard A; Moreau M; De Groote D; Nicolas F; Soulillou JP; Anegon I J Infect Dis; 1995 Jan; 171(1):232-6. PubMed ID: 7798671 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of leukemia inhibitory factor as a marker of ectopic pregnancy. Wegner NT; Mershon JL Am J Obstet Gynecol; 2001 May; 184(6):1074-6. PubMed ID: 11349161 [TBL] [Abstract][Full Text] [Related]
11. Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity. Viallard JF; Taupin JL; Miossec V; Pellegrin JL; Moreau BL Eur Cytokine Netw; 1999 Mar; 10(1):17-24. PubMed ID: 10210768 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Robak T; Gladalska A; Stepień H; Robak E Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970 [TBL] [Abstract][Full Text] [Related]
13. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Okamoto H; Yamamura M; Morita Y; Harada S; Makino H; Ota Z Arthritis Rheum; 1997 Jun; 40(6):1096-105. PubMed ID: 9182920 [TBL] [Abstract][Full Text] [Related]
14. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma. Wierzbowska A; Urbańska-Ryś H; Robak T Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412 [TBL] [Abstract][Full Text] [Related]
15. Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukaemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody. Fixe P; Lorgeot V; Le Meur Y; Coupey L; Heymann D; Godard A; Praloran V Cytokine; 1996 Jul; 8(7):586-91. PubMed ID: 8891440 [TBL] [Abstract][Full Text] [Related]
16. High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy. Lecron JC; Roblot P; Chevalier S; Morel F; Alderman E; Gombert J; Gascan H Clin Exp Immunol; 1993 Apr; 92(1):23-6. PubMed ID: 8096803 [TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro regulation of thyroid leukemia inhibitory factor (LIF): marker of hypothyroidism. Ren SG; Seliktar J; Li X; Hershman JM; Braunstein GD; Melmed S J Clin Endocrinol Metab; 1999 Aug; 84(8):2883-7. PubMed ID: 10443695 [TBL] [Abstract][Full Text] [Related]
18. Sequential production of leukaemia inhibitory factor by blood cell culture in patients with ARDS. Gruson D; Hilbert G; Juzan M; Taupin JL; Coulon V; Moreau JF; Gualde N; Gbikpi-Benissan G Intensive Care Med; 1998 Apr; 24(4):366-8. PubMed ID: 9609417 [TBL] [Abstract][Full Text] [Related]
19. Pregnancy associated increase in differentiation-stimulating factor (D-factor)/leukemia inhibitory factor (LIF)-binding substance(s) in mouse serum. Yamaguchi-Yamamoto Y; Tomida M; Hozumi M Leuk Res; 1993 Jun; 17(6):515-22. PubMed ID: 8505848 [TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive acidic protein (IAP) and CA 125 assays in detection of human ovarian cancer: preliminary results. Castelli M; Romano P; Atlante G; Pozzi M; Ferrini U Int J Biol Markers; 1987; 2(3):187-90. PubMed ID: 3482661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]